Annual Securities Report — FY2025
What Sumitomo Pharma Co.,Ltd. reported for the period from 2025-04-01 to 2026-03-31. Filed by Sumitomo Pharma Co., Ltd.
Filed 2026-06-23View the original on EDINET
How much it says
68Detailed
What moved here
20named for the first time
Its own wording
54terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
Sumitomo Pharma is advancing sales of its key products, primarily in North America, and increased profit through the transfer of part of its interest in the Asia business under its growth plans as an R&D-focused pharmaceutical company, Reboot 2027 and Boost 2028. The filing also reflects the implementation of a public offering, disclosure of sustainability-related structures and indicators, and updates to and termination of various agreements, including technology licensing and commercial partnerships.
Komori's summary of this document, not the document's own words.68Detailed
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 39 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
96
Very detailed
77
Very detailed
100
Very detailed
62
Detailed
25
Almost nothing
50
Typical
68
Detailed
55
Typical
67
Detailed
60
Detailed
55
Typical
77
Very detailed
R&D spend440億円Money spent making new things.
Cash left over943億円Cash from the business, less what went into equipment.
Spent on equipment660億円Plants, machines — things meant to last.
Employees1,747Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.